These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28272740)

  • 21. Extracellular Matrix-Coated Composite Scaffolds Promote Mesenchymal Stem Cell Persistence and Osteogenesis.
    Harvestine JN; Vollmer NL; Ho SS; Zikry CA; Lee MA; Leach JK
    Biomacromolecules; 2016 Nov; 17(11):3524-3531. PubMed ID: 27744699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
    Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
    J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of collagen-glycosaminoglycan scaffold pore size on matrix mineralization and cellular behavior in different cell types.
    Murphy CM; Duffy GP; Schindeler A; O'brien FJ
    J Biomed Mater Res A; 2016 Jan; 104(1):291-304. PubMed ID: 26386362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dextran sulfate-amplified extracellular matrix deposition promotes osteogenic differentiation of mesenchymal stem cells.
    Wan HY; Shin RLY; Chen JCH; Assunção M; Wang D; Nilsson SK; Tuan RS; Blocki A
    Acta Biomater; 2022 Mar; 140():163-177. PubMed ID: 34875356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The extracellular matrix of human bone marrow adipocytes and glucose concentration differentially alter mineralization quality without impairing osteoblastogenesis.
    Entz L; Falgayrac G; Chauveau C; Pasquier G; Lucas S
    Bone Rep; 2022 Dec; 17():101622. PubMed ID: 36187598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High glucose prevents osteogenic differentiation of mesenchymal stem cells via lncRNA AK028326/CXCL13 pathway.
    Cao B; Liu N; Wang W
    Biomed Pharmacother; 2016 Dec; 84():544-551. PubMed ID: 27693963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal Stem Cells Repress Osteoblast Differentiation Under Osteogenic-Inducing Conditions.
    Santos TS; Abuna RP; Castro Raucci LM; Teixeira LN; de Oliveira PT; Beloti MM; Rosa AL
    J Cell Biochem; 2015 Dec; 116(12):2896-902. PubMed ID: 26013001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human fibroblast-derived extracellular matrix constructs for bone tissue engineering applications.
    Tour G; Wendel M; Tcacencu I
    J Biomed Mater Res A; 2013 Oct; 101(10):2826-37. PubMed ID: 23471711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulfated hyaluronan containing collagen matrices enhance cell-matrix-interaction, endocytosis, and osteogenic differentiation of human mesenchymal stromal cells.
    Kliemt S; Lange C; Otto W; Hintze V; Möller S; von Bergen M; Hempel U; Kalkhof S
    J Proteome Res; 2013 Jan; 12(1):378-89. PubMed ID: 23170904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fucoidan promotes osteoblast differentiation via JNK- and ERK-dependent BMP2-Smad 1/5/8 signaling in human mesenchymal stem cells.
    Kim BS; Kang HJ; Park JY; Lee J
    Exp Mol Med; 2015 Jan; 47(1):e128. PubMed ID: 25572360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone morphogenetic protein-2 enhances the osteogenic differentiation capacity of mesenchymal stromal cells derived from human bone marrow and umbilical cord.
    Marupanthorn K; Tantrawatpan C; Kheolamai P; Tantikanlayaporn D; Manochantr S
    Int J Mol Med; 2017 Mar; 39(3):654-662. PubMed ID: 28204808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway.
    Sonomoto K; Yamaoka K; Oshita K; Fukuyo S; Zhang X; Nakano K; Okada Y; Tanaka Y
    Arthritis Rheum; 2012 Oct; 64(10):3355-63. PubMed ID: 22674197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synergistic interaction of platelet derived growth factor (PDGF) with the surface of PLLA/Col/HA and PLLA/HA scaffolds produces rapid osteogenic differentiation.
    Raghavendran HR; Mohan S; Genasan K; Murali MR; Naveen SV; Talebian S; McKean R; Kamarul T
    Colloids Surf B Biointerfaces; 2016 Mar; 139():68-78. PubMed ID: 26700235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple mechanisms are involved in inhibition of osteoblast differentiation by PTHrP and PTH in KS483 Cells.
    van der Horst G; Farih-Sips H; Löwik CW; Karperien M
    J Bone Miner Res; 2005 Dec; 20(12):2233-44. PubMed ID: 16294276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular matrix protein mediated regulation of the osteoblast differentiation of bone marrow derived human mesenchymal stem cells.
    Mathews S; Bhonde R; Gupta PK; Totey S
    Differentiation; 2012 Sep; 84(2):185-92. PubMed ID: 22664173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.
    Chen XD; Dusevich V; Feng JQ; Manolagas SC; Jilka RL
    J Bone Miner Res; 2007 Dec; 22(12):1943-56. PubMed ID: 17680726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells.
    Shih YR; Tseng KF; Lai HY; Lin CH; Lee OK
    J Bone Miner Res; 2011 Apr; 26(4):730-8. PubMed ID: 20939067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteomic analysis of human mesenchymal stromal cells derived from adipose tissue undergoing osteoblast differentiation.
    Giusta MS; Andrade H; Santos AV; Castanheira P; Lamana L; Pimenta AM; Goes AM
    Cytotherapy; 2010 Jul; 12(4):478-90. PubMed ID: 20230220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alginate hydrogels containing cell-interactive beads for bone formation.
    Bhat A; Hoch AI; Decaris ML; Leach JK
    FASEB J; 2013 Dec; 27(12):4844-52. PubMed ID: 24005905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered extracellular matrix components do not alter the immunomodulatory properties of mesenchymal stromal cells in vitro.
    Wehner R; Taubert C; Mende T; Gaebler C; de Andrade AV; Bornhäuser M; Werner C; Tonn T; Schäkel K; Bachmann M; Schmitz M
    J Tissue Eng Regen Med; 2013 Nov; 7(11):921-4. PubMed ID: 22610974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.